Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Issues
2016
March 2016, Vol 6, No 3
March 2016, Vol 6, No 3
Ninlaro (Ixazomib): First Oral Proteasome Inhibitor Approved for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
By
Lisa A. Raedler, PhD, RPh
Drug Updates
Read More ›
Medications Used for the Treatment of Multiple Myeloma Associated with ICD-10 Codes
By
Kristin A. Esposito, CPhT
ICD Codes
,
Cancer Drug Coding
,
Reimbursement
Read More ›
Innovative Approaches to Dispensing Oral Oncolytics in Community Oncology
By
Michael J. Reff, RPh, MBA
Read More ›
Measuring Outcomes to Improve Quality
By
Chase Doyle
Reimbursement
Medicare is poised to incorporate new quality metrics as a guide for payments. At ASH 2015, Helen Burstin, MD, MPH, Chief Scientific Officer, National Quality Forum, Washington, DC, discussed the need for measures and reporting systems that reflect patient care and care coordination.
Read More ›
Increased Physical Activity May Help Extend Survival After Prostate Cancer Diagnosis
By
Charles Bankhead
Prostate Cancer
Read More ›
Reassuring Practice Patterns in the Use of Curative Treatment for Men with Prostate Cancer
By
Phoebe Starr
Prostate Cancer
Read More ›
Idelalisib Improves Survival in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
By
Phoebe Starr
Leukemia
Read More ›
Three Ways to Save Taxes While You Invest
By
W. Ben, Utley, CFP
;
Lawrence B. Keller, CFP, CLU, ChFC, RHU, LUTCF
Financial Management
,
Practice Management
You pay more than your fair share of taxes, so when it comes to your investments, why would you pay more than you absolutely have to?
Read More ›
Moonshots and Memos: Looming Changes in Oncology
By
Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
Read More ›
A New Paradigm for Survivorship Care: Assessing the Patient’s Priorities
By
Chase Doyle
Survivorship
Read More ›
Page 1 of 2
1
2
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Molecular Characteristics Increasingly Define Adult Gliomas
By
William King
2.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
By
William King
3.
Optimal Systemic Therapy for Renal Cell Carcinoma Is Still Evolving
By
William King
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes